SKN | Iambic Therapeutics Prices $150 Million IPO as AI-Driven Drug Discovery Enters the Public Market
Iambic Therapeutics, Inc. has priced its initial public offering at $16 per share, seeking to raise approximately $150 million as the artificial intelligence-driven biotechnology...
SKN | Tungsten Miners Consider IPOs as Prices Surge to Record Levels
Tungsten miners are increasingly considering public-market listings as a sharp rise in prices and supply constraints create new opportunities for the industry. Two private...
SKN | AGNC Investment Stock Falls 0.99% as Mortgage REIT Trades at $8.52
AGNC Investment Corp. (Nasdaq: AGNC) was trading at $8.52 on October 14, 2026, down $0.09 or 0.99% from its previous close of $8.61. The...
SKN | U.S. IPO Calendar Shows ETF Activity Outpacing Traditional IPOs
Key Points
The October 14 calendar lists 13 expected pricing events, but most entries involve exchange-traded funds, investment vehicles and existing securities rather than...
SKN | Leverage Shares MANGOS ETF Targets AI Giants and Private-Market Exposure in a Single Fund
The Leverage Shares MANGOS ETF is designed to give investors concentrated exposure to six companies shaping the artificial intelligence and technology landscape: Meta Platforms,...